Search Login Register

Arteriosclerosis Summary

Description: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Also Known As: Arterioscleroses

Networked: 3176 relevant articles (68 outcomes, 301 trials/studies) for this Disease

Key Drugs and Agents for Arteriosclerosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cholesterol : 4 outcomes 16 studies in 243 results : IBA
  2. proanthocyanidin : 3 outcomes in 3 results : IBA
  3. Lipoproteins (Lipoprotein) : 2 outcomes 18 studies in 137 results : IBA
  4. Biological Markers (Surrogate Marker) : 2 outcomes 5 studies in 26 results : IBA
  5. Aspirin (Acetylsalicylic Acid) : 2 outcomes in 14 results : FDA 80 Generic
  6. Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase) : 2 outcomes in 11 results : IBA
  7. pioglitazone (Actos) : 2 outcomes in 7 results : FDA 9
  8. rho-Associated Kinases : 1 outcome 6 studies in 22 results : IBA
  9. Heparin (Liquaemin) : 1 outcome 5 studies in 44 results : FDA 74 Generic
  10. Glucose (Dextrose) : 1 outcome 5 studies in 41 results : FDA 175 Generic
Show All >>

Diseases Related to Arteriosclerosis

  1. Hypertension (High Blood Pressure)
  2. Obesity
  3. Inflammation
  4. Infection
  5. Neoplasms (Cancer)
Show All >>

Key Therapies for Arteriosclerosis

Efficacy Chart >>
  1. Transplants (Transplant) : 18 outcomes 82 studies in 517 results
  2. Homologous Transplantation (Allograft) : 7 outcomes 30 studies in 252 results
  3. Transplantation (Transplant Recipients) : 2 outcomes 6 studies in 108 results
  4. Heart Transplantation (Grafting, Heart) : 2 outcomes 3 studies in 50 results
  5. Kidney Transplantation : 2 outcomes 1 study in 17 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.